✨ Your Portfolio is fetched and updated from zerodha.
Micro Pharmaceuticals
Market Cap
₹5 Cr.
P/E
0.00
  • Zyden Gentec
  • MPS Pharmaa
  • Kobo Biotech
FAQs on Zyden Gentec Ltd. Shareprice

Zyden Gentec has given lower returns compared to its competitors.
Zyden Gentec has grown at ~0.0% over the last 3yrs while peers have grown at a median rate of 9.57%

There is insufficient historical data to gauge this.
Latest PE of Zyden Gentec is 0

Growth Table
  • Zyden Gentec Ltd.
  • MPS Pharmaa
  • Kobo Biotech
Balance Sheet
  • Zyden Gentec Ltd.
  • MPS Pharmaa
  • Kobo Biotech
Balance Sheet Snapshot
No data available.
Fund Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end
Profit & Loss
  • Zyden Gentec Ltd.
  • MPS Pharmaa
  • Kobo Biotech
Cash Flow
  • Zyden Gentec Ltd.
  • MPS Pharmaa
  • Kobo Biotech
Cash Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
Ratios
= Dominant Factor
  • Zyden Gentec Ltd.
  • MPS Pharmaa
  • Kobo Biotech
Quarterly Results
  • Zyden Gentec Ltd.
  • MPS Pharmaa
  • Kobo Biotech
Reverse DCF
locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
FAQs on Zyden Gentec Ltd. Financials

Zyden Gentec balance sheet is weak and might have solvency issues

The net debt of Zyden Gentec is decreasing.
Latest net debt of Zyden Gentec is ₹2 Crs as of Mar-19.
This is less than Mar-18 when it was ₹4.5 Crs.

No, profit is decreasing.
The profit of Zyden Gentec is -₹3.77 Crs for Mar 2019, -₹2.18 Crs for Mar 2018 and -₹0.01 Crs for Mar 2017

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Zyden Gentec latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%

Companies resources are allocated to majorly productive assets like Plant & Machinery and unproductive assets like Cash & Short Term Investments, Capital Work in Progress, Inventory, Short Term Loans & Advances

Ideas Dashboard
Timeline
Watchlist
Portfolio
Alerts
Research
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech